NASDAQ:PCSA Heatwurx Q4 2024 Earnings Results & Report $1.69 -0.01 (-0.59%) Closing price 04:00 PM EasternExtended Trading$1.42 -0.27 (-16.15%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Heatwurx beat analyst earnings expectations in its Q4 2024 results, released March 20, 2025. The company reported EPS of -$18.50 versus the -$23.00 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2024Report DateMarch 20, 2025TimeAfter Market ClosesConference Call3:00 AM ET Heatwurx EPS ResultsActual EPS-$18.50Consensus EPS -$23.00Beat/MissBeat by +$4.50One Year Ago EPSN/AEPS Beat Rate3 of last 8 quartersHeatwurx Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesAnnual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsAnnual report(10-K) Heatwurx Q4 2024 Earnings FAQ Did Heatwurx beat earnings estimates for Q4 2024? Heatwurx (NASDAQ:PCSA) reported earnings of -$18.50 per share for Q4 2024, beating the consensus estimate of -$23.00. The report was announced on Thursday, March 20, 2025. Heatwurx Earnings HeadlinesProcessa Pharmaceuticals to Participate in Upcoming Investor ConferencesNovember 5, 2026 | globenewswire.comProcessa Pharmaceuticals Announces Key Leadership AppointmentsNovember 4, 2026 | globenewswire.comELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.November 19 at 1:00 AM | Paradigm Press (Ad)Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya TherapeuticsOctober 29, 2026 | globenewswire.comProcessa Pharmaceuticals to Participate in Upcoming Investor ConferencesSeptember 1, 2026 | globenewswire.comProcessa Pharmaceuticals, Inc. (PCSA) M&A Call Prepared Remarks TranscriptJuly 29, 2026 | seekingalpha.comSee More Heatwurx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Heatwurx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heatwurx and other key companies, straight to your email. Email Address About HeatwurxHeatwurx (NASDAQ:PCSA) was an asphalt pavement repair technology company. It developed infrared-based equipment and repair methods intended to heat and reuse existing pavement, serving the road and pavement maintenance industry. Heatwurx is a historical company name associated with the business now identified by Nasdaq ticker PCSA. The public company operates as Processa Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious medical conditions.View Heatwurx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play ItLowe's Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the MathApple's Next Margin Defense Could Be Hiding in Your WalletThe Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027Target Stock Is Up Over 70%—Has the Easy Money Already Been Made? Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.